Extended-infusion of Piperacillin-Tazobactam Versus Intermittent Infusion
NCT04895657
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Gram-Negative Infections
Interventions
DRUG:
Piperacillin/Tazobactam Continuous infusion
DRUG:
Piperacillin/Tazobactam Intermittent infusion
Sponsor
Ain Shams University